TV presenter Ruth Langsford has opened up about her fears of a condition that has deeply affected her family, and her split ...

BI-778 is a unique substrate competitive brain penetrant PRMT5 inhibitor that has shown no adverse effects in preclinical ...

There are four dementia-specific medications approved in Australia – donepezil, galantamine, rivastigmine, and memantine.

This Morning presenter Ruth Langsford has opened up on her fear of developing Alzheimer's disease, having witnessed both her ...

This content was published on Oct 24, 2024 On Thursday, the Swiss Federal Railways presented its first fully renovated InterCity tilting train (ICN). Read more: Swiss railways presents first fully ...

Expanding public education, increasing access and quality of care, supporting family caregivers and increasing training for ...

Though Lilly has been in the spotlight for the success of its GLP-1 drugs, the pharma giant has also been investing in a corporate brand campaign to boost its overall reputation.

NICE has said the Alzheimer's disease drug is too expensive to be available on the NHS, but researchers are now hoping to ...

Donanemab and another new drug for Alzheimer’s called Lecanemab have been billed as a huge step forward in research ...

Diagnosed with mild cognitive impairment (MCI) in 2018, Mr Almond, from Esher, took part in two 18-month trials for donanemab ...